Acquisitions and Equity Raising

EBOS announces that consistent with EBOS’ strategy of investing for growth, the Group has completed two acquisitions (together, the “Acquisitions”) since the commencement of the second half of FY25:
- EBOS acquired SVS Veterinary Supplies (“SVS”)(1), a leading supplier of pet medicines and other products to veterinary clinics and specialty retailers in New Zealand for upfront consideration of NZ$115 million and an earn-out of up to NZ$10 million. The upfront acquisition price represents approximately 7x EBITDA for the twelve months to 31 March 2025(2)
- As previously announced, EBOS has acquired the remaining 10% stake in Transmedic that it did not already own for consideration of approximately A$35 million

EBOS will raise approximately A$200 million (NZ$217 million) via an underwritten placement and will undertake a non-underwritten retail offer to raise up to A$50 million (NZ$54 million)(3)

Funds raised in excess of the amounts paid for the Acquisitions will provide further balance sheet capacity to fund additional future growth opportunities.

Please see attachments for full details.


(1) Acquisition includes SVS Veterinary Supplies Limited and associated entities. The purchase price is subject to customary adjustment mechanisms for movements (if any) in working capital and net debt.
(2) Based on management forecasts and actual results for 11 months to 28 February 2025.
(3) EBOS has discretion to accept oversubscriptions above this amount.

---

Announcement PDF